Obesity involves disrupted appetite peptide signaling at multiple levels — reduced satiety responses (GLP-1, PYY), altered reward processing (endorphins), and ghrelin dysregulation — creating a biology that drives overeating.
Key findingEating behavior in obesity reflects disrupted multi-level peptide signaling: blunted gut satiety peptides (GLP-1, PYY, CCK), altered opioid reward pro
What the researchers found
Eating behavior in obesity reflects disrupted multi-level peptide signaling: blunted gut satiety peptides (GLP-1, PYY, CCK), altered opioid reward processing, ghrelin dysregulation, and impaired central neuropeptide circuits — biology driving behavioral excess.
Why it matters
Relevant for glp-1, neuropeptides, weight-loss.
How the study worked
review study on glp-1, neuropeptides.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2004.
The bigger picture
Advances peptide therapeutics research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Biology of eating behavior in obesity.
Obesity research, 12 Suppl 2, 102S-6S
Citation
Schwartz, Gary J. (2004). Biology of eating behavior in obesity.. Obesity research, 12 Suppl 2, 102S-6S.